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INTRODUCTION
The effect of the ACTN3 genotype has mainly been 
studied in elite athletes, based on the hypothesis that 
its influence on muscle function would be most readily 
observable at the extremes of human performance. The X 
allele tends to be overrepresented in those humans with an 
‘extreme endurance phenotype’, i.e. elite endurance athletes 
(1-2). The aim of this study was to examine the genotype 
distribution of the R577X polymorphism (rs1815739) in 
?-actinin-3 (ACTN3) gene among marathon athletes. 
METHODS
Participants of the study were 173 men athletes with 
best personal time <3h in marathon (mean age=43.06 
years). The control group consisted of 216 non-athletes 
male young adults (mean age=20.73 years). Genotyping 
was performed by polymerase chain reaction. We used 
the chi-square test to determine whether the genotypic 
frequencies of the ACTN3 R577X genotypes differed 
between groups and logistic regression to calculate 
the odds ratio for being an marathoner based on the 
aforementioned genotypes. The SPSS 18.0 program was 
used for all statistical analyses. 
RESULTS
Genotype allele frequencies were similar between mara-
thon atlethes and control groups (P>0.05). We did not find 
an association between the ACTN3 R577X polymorphism 
and the likelihood of being an atlethe marathon using the 
dominant (RR vs. RX+XX) and the recessive model (RR+RX 
vs. XX). 
DISCUSSION
The ACTN3 R577X polymorphism is not associated with 
marathon athlete status, at least in the cohort we studied. 
These results were theoretically unexpected, given the role 
of ?-actinin-3 on skeletal muscle phenotypes, particularly 
muscle endurance and the importance of this phenotype 
for marathon performance. 
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